Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Suyu Gao is active.

Publication


Featured researches published by Suyu Gao.


Fitoterapia | 2015

Cadinane sesquiterpenes from Curcuma phaeocaulis with their inhibitory activities on nitric oxide production in RAW 264.7 cells.

Jianghao Ma; Ying Wang; Yue Liu; Suyu Gao; Liqin Ding; Feng Zhao; Lixia Chen; Feng Qiu

Four new cadinane-type sesquiterpenes named phacadinanes A-D (1-4) were isolated from the rhizomes of Curcuma phaeocaulis. Their structures were elucidated by 1D and 2D NMR, as well as accurate mass measurements. Compound 4 was the first example of a rare 4,5-seco-cadinane sesquiterpene isolated from the Zingiberaceae family. Furthermore, inhibitory effects of the isolated compounds on nitric oxide production in LPS-activated macrophages were evaluated. Compounds 1 and 2 showed strong inhibitory activities on NO production with IC50 values of 3.88±0.58 and 2.25±0.71 μM, respectively. A possible biogenetic pathway for 4,5-seco-cadinane sesquiterpene (4) was postulated.


Natural Product Research | 2017

Sesquiterpenes from Curcuma wenyujin with their inhibitory activities on nitric oxide production in RAW 264.7 cells

Suyu Gao; Guiyang Xia; Liqing Wang; Li Zhou; Feng Zhao; Jian Huang; Lixia Chen

Abstract One new sesquiterpene, 7α,11-epoxy-6α-hydroxy-carabrane-4,8-dione, along with 10 known ones were isolated from the essential oil of Curcuma wenyujin Y.H. Chen et C. Ling. Their structures were established based on extensive spectroscopic analysis. The absolute configuration of compound 1 was determined by the CD analysis of the insitu formed [Rh2(OCOCF3)4] complex, and the CD data analysis based on the octane rule of cyclohexanone. The inhibitory effects of these sesquiterpenes on nitric oxide production in lipopolysaccharide-activated macrophages were also evaluated. Furthermore, the biosynthesis pathway of the isolated compounds was proposed.


Journal of Asian Natural Products Research | 2015

Four new sesquiterpenes from the rhizomes of Curcuma phaeocaulis and their iNOS inhibitory activities

Jianghao Ma; Ying Wang; Yue Liu; Suyu Gao; Liqin Ding; Feng Zhao; Lixia Chen; Feng Qiu

Three new guaiane-type sesquiterpenes named phaeocaulisins K-M (1–3), and one germacrane-type sesquiterpenoid with new ring system of 1,5- and 1,8-ether groups named phagermadiol (4), were isolated from rhizomes of Curcuma phaeocaulis. Their structures were established based on extensive spectroscopic analysis. Compound 1, the first example of norsesquiterpene with tropone backbone, and compound 3 with a novel 1,2-dioxolane sesquiterpene alcohol were isolated from the genus Curcuma. All of the isolated compounds were tested for inhibitory activity against lipopolysaccharide-induced nitric oxide (NO) production in RAW 264.7 macrophages. Compound 3 inhibited NO production with IC50 value of 6.05 ± 0.43 μM. The plausible biosynthetic pathway for compounds 3 and 4 in C. phaeocaulis was also discussed.


Oncotarget | 2017

Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1

Mengzhu Zheng; Weiguang Sun; Suyu Gao; Shanshan Luan; Dan Li; Renqi Chen; Qian Zhang; Lixia Chen; Jiangeng Huang; Hua Li

Isocitrate dehydrogenase (IDH) plays an indispensable role in the tricarboxylic acid cycle, and IDH mutations are present in nearly 75% of glioma and 20% of acute myeloid leukemia. One IDH1R132H inhibitor (clomifene citrate) was found by virtual screening method, which can selectively suppress mutant enzyme activities in vitro and in vivo with a dose-dependent manner. The molecular docking indicated that clomifene occupied the allosteric site of the mutant IDH1. Enzymatic kinetics also demonstrated that clomifene inhibited mutant enzyme in a non-competitive manner. Moreover, knockdown of mutant IDH1 in HT1080 cells decreased the sensitivity to clomifene. In vivo studies indicated that clomifene significantly suppressed the tumor growth of HT1080-bearing CB-17/Icr-scid mice with oral administration of 100 mg/kg and 50 mg/kg per day. In short, our findings highlight clomifene may have clinical potential in tumor therapies as a safe and effective inhibitor of mutant IDH1.


Fitoterapia | 2018

New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense

Fengyan Bao; Kaiyin Yang; Canrong Wu; Suyu Gao; Penghe Wang; Lixia Chen; Hua Li

Hexokinase 2 (HK2), a rate-limiting enzyme in the first step of glycolysis pathway, expresses at high level in cancer cells compared with normal cells. HK2 provides a new target for cancer therapy due to its pivotal role in tumor tumourigenic and metastatic process. The structure-based virtual ligand screening in a small in-house database of natural products predicted that a new steroid, (22E,24R)-6β-methoxyergosta-7,9(11),22-triene-3β,5α-diol (2) from Ganoderma sinense has high binding affinity to HK2 with significant calculated binding free energy. Based on this prediction, compound 2, together with the other 12 steroid analogues (1, 3-13) from this plant were selected for further in vitro microscale thermophoresis (MST), enzyme inhibition, and cell-based assays based on the HK2 target. And compound 2 was finally identified as an HK2 inhibitor. As the first natural HK2 inhibitor, compound 2 can be considered as a potential drug candidate targeting at HK2 for cancer therapy.


Oncotarget | 2017

Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase

Mengzhu Zheng; Shanshan Luan; Suyu Gao; Li Cheng; Bin Hao; Jiacheng Li; Yao Chen; Xuemei Hou; Lixia Chen; Hua Li

T-cell-originated protein kinase (TOPK) is highly and frequently expressed in various cancer tissues and plays an indispensable role in the mitosis of cancer cells, and therefore, it is an important target for drug treatment of tumor. Ilaprazole was identified to be a potent TOPK inhibitor. The data indicated that ilaprazole inhibited TOPK activities with high affinity and selectivity. In vitro studies showed that ilaprazole inhibited TOPK activities in HCT116, ES-2, A549, SW1990 cancer cells. Moreover, knockdown of TOPK in these cells decreased their sensitivities to ilaprazole. Results of an in vivo study demonstrated that gavage of ilaprazole in HCT116 colon tumor-bearing mice effectively suppressed cancer growth. The TOPK downstream signaling molecule phospho-histone H3 in tumor tissues was also decreased after ilaprazole treatment. Our results suggested that ilaprazole inhibited the cancer growth by targeting TOPK both in vitro and in vivo.


Oncotarget | 2017

A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity

Canrong Wu; Mengzhu Zheng; Suyu Gao; Shanshan Luan; Li Cheng; Liqing Wang; Jiachen Li; Lixia Chen; Hua Li

Kidney-type glutaminase (KGA), a mitochondrial enzyme converting glutamine to glutamate for energy supply, was over-expressed in many cancers and had been regarded as a promising therapeutic target in recent years. Structure-based virtual ligand screening predicted physapubescin K, a new withanolide from Physalis pubescens, to be potential KGA inhibitor. Enzyme activity inhibition assays and microscale thermophoresis experiments had demonstrated the efficiency and specificity of physapubescin K targeting KGA. Additionally, physapubescin K exhibited potent proliferation inhibitory effects on a panel of human cancer cell lines, such as SW1990 and HCC827-ER. It blocked glutamine metabolism in SW1990 with increasing intracellular level of glutamine and decreasing glutamate and its downstream metabolites. Physapubescin K also significantly inhibited the tumor growth in a SW1990 xenograft mouse model. Interestingly, physapubescin K could reverse the resistance of HCC827-ER cells to erlotinib and synergize with the hexokinase 2 inhibitor to markedly enhance the inhibition of SW1990 cell proliferation.


Fitoterapia | 2018

Meroterpenoids from Ganoderma sinense protect hepatocytes and cardiomyocytes from oxidative stress induced injuries

Suyu Gao; Peng Zhang; Cuiyun Zhang; Fengyan Bao; Hua Li; Lixia Chen

Four meroterpenoids, applanatumols F (1), H (3), I (2), and lingzhiol (4) were isolated from the 95% EtOH extract of the fruiting bodies of Ganoderma sinense. Their structures were established on the basis of NMR spectroscopic analyses, optical rotatory dispersion data, ECD spectra, and X-ray crystallography. Compounds 1, 2, 4 existed as racemic mixtures ((+) 1a, 2a, 4a; (-) 1b, 2b, 4b), while 3 as a single enantiomer. Base on the seperated enantiomers, we sought to explicit possible effects of compounds 1-4 on hydrogen peroxide (H2O2)-induced cell death and to determine their underlying molecular mechanisms in human normal liver LO2 cells. Among them, compound 2a treatment effectively protected LO2 cells against H2O2-induced cell damage and apoptosis. H2O2 exposure increased ROS, which was inhibited by 2a treatment. Mitochondrial membrane potential decrease, nuclear fragments, caspase-3 activation and PARP cleavage were also arrested by 2a. Further, increased levels of Nrf2, HO-1, phosphorylation Akt and up-regulation of antioxidant enzymes were detected in 2a treated cells, indicating that the anti-oxidative effects of 2a might protect LO2 cells against oxidative damage via PI3K/Akt-mediated activation of Nrf2/HO-1 pathway. In addition, compound 2a showed potential protective role of cardiomyocyte from ischemia/reperfusion injury, and pretreatment with 2a could decrease CK and LDH levels and increase GSH level.


European Journal of Organic Chemistry | 2014

Eudesmane-Type Sesquiterpenes from Curcuma phaeocaulis and Their Inhibitory Activities on Nitric Oxide Production in RAW 264.7 Cells

Yue Liu; Jianghao Ma; Ying Wang; Paul Owusu Donkor; Qin Li; Suyu Gao; Yaguang Hou; Yang Xu; Jianing Cui; Liqin Ding; Feng Zhao; Ning Kang; Lixia Chen; Feng Qiu


Organic and Biomolecular Chemistry | 2015

Natural nitric oxide (NO) inhibitors from the rhizomes of Curcuma phaeocaulis

Jiang-Hao Ma; Feng Zhao; Ying Wang; Yue Liu; Suyu Gao; Liqin Ding; Lixia Chen; Feng Qiu

Collaboration


Dive into the Suyu Gao's collaboration.

Top Co-Authors

Avatar

Lixia Chen

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Hua Li

Huazhong University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Ying Wang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Feng Qiu

Tianjin University of Traditional Chinese Medicine

View shared research outputs
Top Co-Authors

Avatar

Liqin Ding

Tianjin University of Traditional Chinese Medicine

View shared research outputs
Top Co-Authors

Avatar

Yue Liu

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Liqing Wang

Shenyang Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Mengzhu Zheng

Huazhong University of Science and Technology

View shared research outputs
Top Co-Authors

Avatar

Fengyan Bao

Shenyang Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge